Group IBSA

The pharmaceutical company IBSA (Institut Biochimique SA) was founded by three Swiss biologists after the Second World War. After the first phase of consolidation at the national and international level, the company began to develop rapidly in 1985 under the leadership of its current owner, Dr. Artura Licenziatiho.

The new management of the pharmaceutical company has chosen a strategy of active principles, the development of innovative pharmaceutical forms, as well as the optimization of therapeutic efficacy and tolerability of the drug. They thus met the requirements of patients and at the same time improved the therapeutic effect of drugs. With this successful concept, IBSA has established itself not only in Switzerland but also worldwide.

The company operates in approximately 50 countries on 4 continents. Not only in the world, but also in our country, IBSA has established itself with the quality of its products adapted to the needs of patients. Due to the size of the territory, marketing activities are managed either by the company's branches or by carefully selected licensees. Compared to aggressive forms of promotion, IBSA's marketing activities focus exclusively on truthful information and marketing support designed to meet the relevant needs of physicians and patients.